Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors-Reference-Cited by-同舟云学术

Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors

Published:2012-08-22 Issue:5 Volume:70 Page:653-663
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Dubbelman Anne-Charlotte,Upthagrove Alana,Beijnen Jos H.,Marchetti Serena,Tan Eugene,Krone Kimberly,Anand Suraj,Schellens Jan H. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-012-1947-2.pdf

Reference14 articles.

1. Dvorak HF (2003) Rous–Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 162:1747–1757. doi: 10.1016/S0002-9440(10)64309-X

2. Haugsten EM, Wiedlocha A, Olsnes S, Wesche J (2010) Roles of fibroblast growth factor receptors in carcinogenesis. Mol Cancer Res 8:1439–1452. doi: 10.1158/1541-7786.MCR-10-0168

3. Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:116–129. doi: 10.1038/nrc2780

4. Fernando NT, Koch M, Rothrock C, Gollogly LK, D’Amore PA, Ryeom S, Yoon SS (2008) Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. Clin Cancer Res 14:1529–1539. doi: 10.1158/1078-0432.CCR-07-4126

5. Welti JC, Gourlaouen M, Powles T, Kudahetti SC, Wilson P, Berney DM, Reynolds AR (2011) Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib. Oncogene 30:1183–1193. doi: 10.1038/onc.2010.503

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of drugs targeting PDGF/PDGFR;Drug Discovery Today;2024-07

2. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers;Drug Resistance Updates;2023-03

3. Federated learning framework integrating REFINED CNN and Deep Regression Forests;Bioinformatics Advances;2023-01-01

4. easyPheno: An easy-to-use and easy-to-extendPythonframework for phenotype prediction using Bayesian optimization;Bioinformatics Advances;2023-01-01

5. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023